{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:24:56Z","timestamp":1787030696311,"version":"build-2736575974"},"reference-count":28,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.3892\/ol.2013.1376","type":"journal-article","created":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T07:39:28Z","timestamp":1370331568000},"page":"537-541","source":"Crossref","is-referenced-by-count":34,"title":["Immune response, clinical outcome and safety of dendritic cell vaccine in combination with cytokine-induced killer cell therapy in cancer patients"],"prefix":"10.3892","volume":"6","author":[{"given":"YU","family":"CUI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XUEJING","family":"YANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WEI","family":"ZHU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIALI","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XIAOJING","family":"WU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YAN","family":"PANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2013,6,4]]},"reference":[{"key":"key20180108110010_b1-ol-06-02-0537","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"issue":"Electronic Suppl 1","key":"key20180108110010_b2-ol-06-02-0537","doi-asserted-by":"crossref","first-page":"eS32","DOI":"10.3949\/ccjm.79.s2.07","article-title":"Locally advanced non-small cell lung cancer: what is the optimal concurrent chemoradiation regimen?","volume":"79","author":"Videtic","year":"2012","journal-title":"Cleve Clin J Med"},{"key":"key20180108110010_b3-ol-06-02-0537","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11748-011-0832-y","article-title":"Optimal radiotherapy for non-small-cell lung cancer: current progress and future challenges","volume":"60","author":"Ishikura","year":"2012","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"key20180108110010_b4-ol-06-02-0537","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.bpg.2010.06.005","article-title":"Evidence for colorectal cancer screening","volume":"24","author":"Bretthauer","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"key20180108110010_b5-ol-06-02-0537","doi-asserted-by":"crossref","first-page":"e1000102","DOI":"10.4172\/2168-9431.1000102","article-title":"Vaccine immunotherapy strategies in colorectal cancer treatment","volume":"1","author":"Niccolai","year":"2012","journal-title":"Single Cell Biol"},{"key":"key20180108110010_b6-ol-06-02-0537","doi-asserted-by":"crossref","first-page":"e42289","DOI":"10.1371\/journal.pone.0042289","article-title":"Vaccination with embryonic stem cells protects against lung cancer: is a broad-spectrum prophylactic vaccine against cancer possible?","volume":"7","author":"Yaddanapudi","year":"2012","journal-title":"PLoS One"},{"key":"key20180108110010_b7-ol-06-02-0537","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/bcr3184","article-title":"Targeting breast cancer vaccines to dendritic cells: improved immunological responses with less protein?","volume":"14","author":"Armstrong","year":"2012","journal-title":"Breast Cancer Res"},{"key":"key20180108110010_b8-ol-06-02-0537","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.smim.2010.03.002","article-title":"Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors","volume":"22","author":"Kalinski","year":"2010","journal-title":"Semin Immunol"},{"key":"key20180108110010_b9-ol-06-02-0537","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-immunol-100311-102839","article-title":"Decisions about dendritic cells: past, present, and future","volume":"30","author":"Steinman","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"key20180108110010_b10-ol-06-02-0537","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1158\/1078-0432.CCR-10-2138","article-title":"A randomized trial of ex vivo CD40L activation of a dendritic cell vaccine in colorectal cancer patients: tumor-specific immune responses are associated with improved survival","volume":"16","author":"Barth","year":"2010","journal-title":"Clin Cancer Res"},{"key":"key20180108110010_b11-ol-06-02-0537","doi-asserted-by":"crossref","first-page":"5725","DOI":"10.1158\/1078-0432.CCR-11-1261","article-title":"Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients","volume":"17","author":"Lesterhuis","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key20180108110010_b12-ol-06-02-0537","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1172\/JCI31205","article-title":"DC-based cancer vaccines","volume":"117","author":"Gilboa","year":"2007","journal-title":"J Clin Invest"},{"key":"key20180108110010_b13-ol-06-02-0537","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/14653249.2011.649185","article-title":"Cytokine-induced killer cells in the treatment of patients with solid carcinomas: a systematic review and pooled analysis","volume":"14","author":"Ma","year":"2012","journal-title":"Cytotherapy"},{"key":"key20180108110010_b14-ol-06-02-0537","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1189\/jlb.0506305","article-title":"Cytokine-induced killer T cells kill immature dendritic cells by TCR-independent and perforin-dependent mechanisms","volume":"80","author":"Joshi","year":"2006","journal-title":"J Leukoc Biol"},{"key":"key20180108110010_b15-ol-06-02-0537","first-page":"55","article-title":"Different antitumor immunity roles of cytokine activated T lymphocytes from naive murine splenocytes and from dendritic cells-based vaccine primed splenocytes: implications for adoptive immunotherapy","volume":"26","author":"Zhang","year":"2004","journal-title":"Eksp Onkol"},{"key":"key20180108110010_b16-ol-06-02-0537","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1479-0556-2-12","article-title":"Human cytokine-induced killer cells have enhanced in vitro cytolytic activity via non-viral interleukin-2 gene transfer","volume":"2","author":"Nagaraj","year":"2004","journal-title":"Genet Vaccines Ther"},{"key":"key20180108110010_b17-ol-06-02-0537","doi-asserted-by":"crossref","first-page":"e12367","DOI":"10.1371\/journal.pone.0012367","article-title":"Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer","volume":"5","author":"Frank","year":"2010","journal-title":"PLoS One"},{"key":"key20180108110010_b18-ol-06-02-0537","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.1158\/1078-0432.CCR-10-3105","article-title":"Comparison of clinical and immunological effects of intravenous and intradermal administration of \u03b1-galactosylceramide (KRN7000)-pulsed dendritic cells","volume":"17","author":"Nicol","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key20180108110010_b19-ol-06-02-0537","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/mt.2011.29","article-title":"Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF","volume":"19","author":"Zhang","year":"2011","journal-title":"Mol Ther"},{"key":"key20180108110010_b20-ol-06-02-0537","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/14653249.2011.649185","article-title":"Cytokine-induced killer cells in the treatment of patients with solid carcinomas: a systematic review and pooled analysis","volume":"14","author":"Ma","year":"2012","journal-title":"Cytotherapy"},{"key":"key20180108110010_b21-ol-06-02-0537","first-page":"1244","article-title":"Specific immune cell therapy against ovarian cancer in vivo and in vitro","volume":"27","author":"Chang","year":"2008","journal-title":"Ai Zheng"},{"key":"key20180108110010_b22-ol-06-02-0537","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2249.2011.04489.x","article-title":"Generation of anti-tumour immune response using dendritic cells pulsed with carbonic anhydrase IX-Acinetobacter baumannii outer membrane protein A fusion proteins against renal cell carcinoma","volume":"167","author":"Kim","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"key20180108110010_b23-ol-06-02-0537","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.1158\/1078-0432.CCR-08-3240","article-title":"Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-(alpha)2a therapy in metastatic renal cell carcinoma patients","volume":"15","author":"Schwaab","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20180108110010_b24-ol-06-02-0537","doi-asserted-by":"crossref","first-page":"517493","DOI":"10.1155\/2010\/517493","article-title":"Dendritic cell-based immunotherapy for prostate cancer","volume":"2010","author":"J\u00e4hnisch","year":"2010","journal-title":"Clin Dev Immunol"},{"key":"key20180108110010_b25-ol-06-02-0537","first-page":"hge12522","article-title":"DC Vaccine therapy combined concurrently with oral capecitabine in meta-static colorectal cancer patients","volume":"60","author":"Liu","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"key20180108110010_b26-ol-06-02-0537","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1479-5876-9-138","article-title":"Biomarkers in T cell therapy clinical trials","volume":"9","author":"Kalos","year":"2011","journal-title":"J Transl Med"},{"key":"key20180108110010_b27-ol-06-02-0537","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/107327481001700307","article-title":"Developing an effective breast cancer vaccine","volume":"17","author":"Soliman","year":"2010","journal-title":"Cancer Control"},{"key":"key20180108110010_b28-ol-06-02-0537","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/jnci\/djq310","article-title":"Improved endpoints for cancer immunotherapy trials","volume":"102","author":"Hoos","year":"2010","journal-title":"J Natl Cancer Inst"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2013.1376\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T14:14:16Z","timestamp":1595859256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2013.1376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,4]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,6,4]]},"published-print":{"date-parts":[[2013,8]]}},"alternative-id":["10.3892\/ol.2013.1376"],"URL":"https:\/\/doi.org\/10.3892\/ol.2013.1376","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,4]]}}}